News

News
eau24
VitaDX will be present at EAU24
3 avril 2024 -
Actualités
Lire la suite
VitaDX
VitaDX selected by Pfizer and WILCO to be part of the new #PfizerHealthcareHub France promo
16 janvier 2024 -
Actualités
Lire la suite
Announcement
Avero Diagnostics and VitaDX announce the signing of a strategic partnership for the distribution in the United States of VisioCyt® Bladder, a diagnostic test for bladder cancer
18 décembre 2023 -
Actualités
Lire la suite
CFU et Carrefour Pathologie
VitaDX at CFU and Carrefour Pathologie!
17 novembre 2023 -
Actualités
Lire la suite
Sowefund
Launch of the participatory financing campaign!
14 novembre 2023 -
Actualités

It's official: the Sowefund crowdfunding campaign is now public and open to all!…

Lire la suite
VitaDX
VitaDX wins France2030's "Medical Imaging" call for projects!
18 octobre 2023 -
Actualités
Lire la suite
JT 20h TF1
VisioCyt® on TF1!
8 juin 2023 -
Actualités

A big thank you to the TF1 Group for this report broadcast on June 07, 2023 on the 8:00 pm news, showing the benefits of Artificial Intelligence…

Lire la suite
VitaDX
Come and meet us !
2 janvier 2023 -
Actualités

We will be present at several events in 2023. If you'd like to find out more about us and VisioCyt, our first innovative solution for bladder…

Lire la suite
masterclass
Mltidisciplinary Masterclass dedicated to prostate and bladder cancers
8 juillet 2022 -
Actualités

Multidisciplinary Masterclass organized by the American Hospital in Paris, MEDIPATH and Ibex Medical Analytics dedicated to prostate and bladder…

Lire la suite